• Je něco špatně v tomto záznamu ?

Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry

MK. Turagam, P. Neuzil, B. Schmidt, T. Reichlin, K. Neven, A. Metzner, J. Hansen, Y. Blaauw, P. Maury, T. Arentz, P. Sommer, A. Anic, F. Anselme, S. Boveda, T. Deneke, S. Willems, P. van der Voort, R. Tilz, M. Funasako, D. Scherr, R. Wakili, D....

. 2023 ; 148 (1) : 35-46. [pub] 20230518

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016932

BACKGROUND: Pulsed field ablation is a novel nonthermal cardiac ablation modality using ultra-rapid electrical pulses to cause cell death by a mechanism of irreversible electroporation. Unlike the traditional ablation energy sources, pulsed field ablation has demonstrated significant preferentiality to myocardial tissue ablation, and thus avoids certain thermally mediated complications. However, its safety and effectiveness remain unknown in usual clinical care. METHODS: MANIFEST-PF (Multi-National Survey on the Methods, Efficacy, and Safety on the Post-Approval Clinical Use of Pulsed Field Ablation) is a retrospective, multinational, patient-level registry wherein patients at each center were prospectively included in their respective center registries. The registry included all patients undergoing postapproval treatment with a multielectrode 5-spline pulsed field ablation catheter to treat atrial fibrillation (AF) between March 1, 2021, and May 30, 2022. The primary effectiveness outcome was freedom from clinical documented atrial arrhythmia (AF/atrial flutter/atrial tachycardia) of ≥30 seconds on the basis of electrocardiographic data after a 3-month blanking period (on or off antiarrhythmic drugs). Safety outcomes included the composite of acute (<7 days postprocedure) and latent (>7 days) major adverse events. RESULTS: At 24 European centers (77 operators) pulsed field ablation was performed in 1568 patients with AF: age 64.5±11.5 years, female 35%, paroxysmal/persistent AF 65%/32%, CHA2DS2-VASc 2.2±1.6, median left ventricular ejection fraction 60%, and left atrial diameter 42 mm. Pulmonary vein isolation was achieved in 99.2% of patients. After a median (interquartile range) follow-up of 367 (289-421) days, the 1-year Kaplan-Meier estimate for freedom from atrial arrhythmia was 78.1% (95% CI, 76.0%-80.0%); clinical effectiveness was more common in patients with paroxysmal AF versus persistent AF (81.6% versus 71.5%; P=0.001). Acute major adverse events occurred in 1.9% of patients. CONCLUSIONS: In this large observational registry of the postapproval clinical use of pulsed field technology to treat AF, catheter ablation using pulsed field energy was clinically effective in 78% of patients with AF.

Asklepios Hospital St Georg Hamburg Germany

Cardiology Department Na Homolce Hospital Homolka Hospital Prague Czechia

Clinic for Electrophysiology Herz und Diabeteszentrum NRW Ruhr University Bochum Bad Oeynhausen Germany

Copenhagen University Hospital Denmark

Department for Cardiovascular Diseases University Hospital Center Split Croatia

Department of Cardiology and Angiology Medical Center and Faculty of Medicine University of Freiburg Germany

Department of Cardiology and Vascular Medicine West German Heart and Vascular Center Essen University Duisburg Essen Germany

Department of Cardiology Catharina Ziekenhuis Eindhoven The Netherlands

Department of Cardiology Jessa Hospitals Hasselt Belgium

Department of Cardiology Rouen Hospital France

Department of Cardiology University Hospital Rangueil Toulouse France

Department of Cardiology University of Groningen University Medical Center Groningen The Netherlands

Department of Electrophysiology Alfried Krupp Hospital Essen Germany

Department of Medicine Witten Herdecke University Germany

Department of Pulmonology Gastroenterology and Internal Medicine Alfried Krupp Hospital Essen Germany

German Center for Cardiovascular Research

Heart Center Bad Neustadt Rhoen Clinic Campus Bad Neustadt Bad Neustadt an der Saale Germany

Heart Center University Hospital of Cologne Department for Electrophysiology Germany

Heart Rhythm Department Clinique Pasteur Toulouse France

I2MC INSERM UMR 1297 Toulouse France

Icahn School of Medicine at Mount Sinai New York NY

IHU LIRYC CHU Bordeaux University of Bordeaux France

IKEM Institute for Clinical and Experimental Medicine Prague Czech Republic

Inselspital Bern University Hospital University of Bern Switzerland

Medical University of Graz Austria

MVZ CCB Frankfurt und Main Taunus GbR Frankfurt Germany

Neuron Medical Brno Czech Republic

Universitair Ziekenhuis VUB Brussels Belgium

University Heart and Vascular Center University Medical Center Hamburg Eppendorf Germany

University Heart Center Lübeck Department of Rhythmology University Hospital Schleswig Holstein Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016932
003      
CZ-PrNML
005      
20231026105445.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCULATIONAHA.123.064959 $2 doi
035    __
$a (PubMed)37199171
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Turagam, Mohit K $u Icahn School of Medicine at Mount Sinai, New York, NY (M.K.T., V.Y.R.) $1 https://orcid.org/0000000181838443
245    10
$a Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry / $c MK. Turagam, P. Neuzil, B. Schmidt, T. Reichlin, K. Neven, A. Metzner, J. Hansen, Y. Blaauw, P. Maury, T. Arentz, P. Sommer, A. Anic, F. Anselme, S. Boveda, T. Deneke, S. Willems, P. van der Voort, R. Tilz, M. Funasako, D. Scherr, R. Wakili, D. Steven, J. Kautzner, J. Vijgen, P. Jais, J. Petru, J. Chun, L. Roten, A. Füting, MD. Lemoine, M. Ruwald, BA. Mulder, A. Rollin, H. Lehrmann, T. Fink, Z. Jurisic, C. Chaumont, R. Adeliño, K. Nentwich, M. Gunawardene, A. Ouss, CH. Heeger, M. Manninger, JE. Bohnen, A. Sultan, P. Peichl, P. Koopman, N. Derval, T. Kueffer, G. Rahe, VY. Reddy
520    9_
$a BACKGROUND: Pulsed field ablation is a novel nonthermal cardiac ablation modality using ultra-rapid electrical pulses to cause cell death by a mechanism of irreversible electroporation. Unlike the traditional ablation energy sources, pulsed field ablation has demonstrated significant preferentiality to myocardial tissue ablation, and thus avoids certain thermally mediated complications. However, its safety and effectiveness remain unknown in usual clinical care. METHODS: MANIFEST-PF (Multi-National Survey on the Methods, Efficacy, and Safety on the Post-Approval Clinical Use of Pulsed Field Ablation) is a retrospective, multinational, patient-level registry wherein patients at each center were prospectively included in their respective center registries. The registry included all patients undergoing postapproval treatment with a multielectrode 5-spline pulsed field ablation catheter to treat atrial fibrillation (AF) between March 1, 2021, and May 30, 2022. The primary effectiveness outcome was freedom from clinical documented atrial arrhythmia (AF/atrial flutter/atrial tachycardia) of ≥30 seconds on the basis of electrocardiographic data after a 3-month blanking period (on or off antiarrhythmic drugs). Safety outcomes included the composite of acute (<7 days postprocedure) and latent (>7 days) major adverse events. RESULTS: At 24 European centers (77 operators) pulsed field ablation was performed in 1568 patients with AF: age 64.5±11.5 years, female 35%, paroxysmal/persistent AF 65%/32%, CHA2DS2-VASc 2.2±1.6, median left ventricular ejection fraction 60%, and left atrial diameter 42 mm. Pulmonary vein isolation was achieved in 99.2% of patients. After a median (interquartile range) follow-up of 367 (289-421) days, the 1-year Kaplan-Meier estimate for freedom from atrial arrhythmia was 78.1% (95% CI, 76.0%-80.0%); clinical effectiveness was more common in patients with paroxysmal AF versus persistent AF (81.6% versus 71.5%; P=0.001). Acute major adverse events occurred in 1.9% of patients. CONCLUSIONS: In this large observational registry of the postapproval clinical use of pulsed field technology to treat AF, catheter ablation using pulsed field energy was clinically effective in 78% of patients with AF.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    12
$a fibrilace síní $x diagnóza $x chirurgie $x farmakoterapie $7 D001281
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a tepový objem $7 D013318
650    _2
$a funkce levé komory srdeční $7 D016277
650    _2
$a výsledek terapie $7 D016896
650    12
$a flutter síní $x etiologie $7 D001282
650    _2
$a registrace $7 D012042
650    12
$a katetrizační ablace $x škodlivé účinky $x metody $7 D017115
650    _2
$a recidiva $7 D012008
650    12
$a venae pulmonales $7 D011667
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Neuzil, Petr $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czechia (P.N., M.F., J.P., V.Y.R.) $1 https://orcid.org/0000000343348165
700    1_
$a Schmidt, Boris $u MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt, Germany (B.S., J.C.) $1 https://orcid.org/0000000153479906
700    1_
$a Reichlin, Tobias $u Inselspital-Bern University Hospital, University of Bern, Switzerland (T.R., L.R., T.K.) $1 https://orcid.org/0000000271978415
700    1_
$a Neven, Kars $u Department of Medicine, Witten/Herdecke University, Germany (K. Neven, A.F., G.R.) $u Department of Electrophysiology, Alfried Krupp Hospital, Essen, Germany (K. Neven, A.F.)
700    1_
$a Metzner, Andreas $u University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Germany (A.M., M.D.L.)
700    1_
$a Hansen, Jim $u Copenhagen University Hospital, Denmark (J.H., M.R.)
700    1_
$a Blaauw, Yuri $u Department of Cardiology, University of Groningen, University Medical Center Groningen, The Netherlands (Y.B., B.A.M.)
700    1_
$a Maury, Philippe $u Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R.) $u I2MC, INSERM UMR 1297, Toulouse, France (P.M.) $1 https://orcid.org/0000000248001841
700    1_
$a Arentz, Thomas $u Department of Cardiology and Angiology, Medical Center and Faculty of Medicine- University of Freiburg, Germany (T.A., H.L.)
700    1_
$a Sommer, Philipp $u Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany (P.S., T.F.)
700    1_
$a Anic, Ante $u Department for Cardiovascular Diseases, University Hospital Center Split, Croatia (A.A., Z.J.) $1 https://orcid.org/0000000268643999
700    1_
$a Anselme, Frédéric $u Department of Cardiology, Rouen Hospital, France (F.A., C.C.) $1 https://orcid.org/0000000221309790
700    1_
$a Boveda, Serge $u Heart Rhythm Department, Clinique Pasteur, Toulouse, France (S.B., R.A.) $u Universitair Ziekenhuis VUB, Brussels, Belgium (S.B., R.A.) $1 https://orcid.org/0000000284253544
700    1_
$a Deneke, Tom $u Heart Center Bad Neustadt, Rhoen-Clinic Campus Bad Neustadt, Bad Neustadt an der Saale, Germany (T.D., K. Nentwich) $1 https://orcid.org/0000000313791684
700    1_
$a Willems, Stephan $u Asklepios Hospital St Georg, Hamburg, Germany (S.W., M.G.)
700    1_
$a van der Voort, Pepijn $u Department of Cardiology, Catharina Ziekenhuis Eindhoven, The Netherlands (P.v.d.V., A.O.)
700    1_
$a Tilz, Roland $u University Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein, Germany (R.T., C.-H.H.) $u German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Germany (R.T., C.-H.H.) $1 https://orcid.org/0000000201227130
700    1_
$a Funasako, Moritoshi $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czechia (P.N., M.F., J.P., V.Y.R.) $u Neuron Medical, Brno, Czech Republic (M.F.)
700    1_
$a Scherr, Daniel $u Medical University of Graz, Austria (D. Scherr, M.M.)
700    1_
$a Wakili, Reza $u Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Germany (R.W., J.-E.B.) $1 https://orcid.org/0000000263261537
700    1_
$a Steven, Daniel $u Heart Center University Hospital of Cologne, Department for Electrophysiology, Germany (D. Steven, A.S.) $1 https://orcid.org/0000000168395895
700    1_
$a Kautzner, Josef $u IKEM-Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K., P.P.) $1 https://orcid.org/0000000216326182 $7 xx0037112
700    1_
$a Vijgen, Johan $u Department of Cardiology, Jessa Hospitals, Hasselt, Belgium (J.V., P.K.) $1 https://orcid.org/0000000349284836
700    1_
$a Jais, Pierre $u IHU LIRYC, CHU Bordeaux, University of Bordeaux, France (P.J., N.D.) $1 https://orcid.org/0000000247007811
700    1_
$a Petru, Jan $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czechia (P.N., M.F., J.P., V.Y.R.)
700    1_
$a Chun, Julian $u MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt, Germany (B.S., J.C.) $1 https://orcid.org/0000000223556015
700    1_
$a Roten, Laurent $u Inselspital-Bern University Hospital, University of Bern, Switzerland (T.R., L.R., T.K.) $1 https://orcid.org/0000000208271329
700    1_
$a Füting, Anna $u Department of Medicine, Witten/Herdecke University, Germany (K. Neven, A.F., G.R.) $u Department of Electrophysiology, Alfried Krupp Hospital, Essen, Germany (K. Neven, A.F.) $1 https://orcid.org/0000000321161690
700    1_
$a Lemoine, Marc D $u University Heart & Vascular Center, University Medical Center Hamburg-Eppendorf, Germany (A.M., M.D.L.) $1 https://orcid.org/0000000237997962
700    1_
$a Ruwald, Martin $u Copenhagen University Hospital, Denmark (J.H., M.R.)
700    1_
$a Mulder, Bart A $u Department of Cardiology, University of Groningen, University Medical Center Groningen, The Netherlands (Y.B., B.A.M.) $1 https://orcid.org/0000000244113918
700    1_
$a Rollin, Anne $u Department of Cardiology, University Hospital Rangueil, Toulouse, France (P.M., A.R.)
700    1_
$a Lehrmann, Heiko $u Department of Cardiology and Angiology, Medical Center and Faculty of Medicine- University of Freiburg, Germany (T.A., H.L.)
700    1_
$a Fink, Thomas $u Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-University Bochum, Bad Oeynhausen, Germany (P.S., T.F.)
700    1_
$a Jurisic, Zrinka $u Department for Cardiovascular Diseases, University Hospital Center Split, Croatia (A.A., Z.J.) $1 https://orcid.org/0000000175839036
700    1_
$a Chaumont, Corentin $u Department of Cardiology, Rouen Hospital, France (F.A., C.C.) $1 https://orcid.org/0000000171882686
700    1_
$a Adeliño, Raquel $u Heart Rhythm Department, Clinique Pasteur, Toulouse, France (S.B., R.A.) $u Universitair Ziekenhuis VUB, Brussels, Belgium (S.B., R.A.) $1 https://orcid.org/0000000288439370
700    1_
$a Nentwich, Karin $u Heart Center Bad Neustadt, Rhoen-Clinic Campus Bad Neustadt, Bad Neustadt an der Saale, Germany (T.D., K. Nentwich) $1 https://orcid.org/0000000235905980
700    1_
$a Gunawardene, Melanie $u Asklepios Hospital St Georg, Hamburg, Germany (S.W., M.G.) $1 https://orcid.org/0000000175617185
700    1_
$a Ouss, Alexandre $u Department of Cardiology, Catharina Ziekenhuis Eindhoven, The Netherlands (P.v.d.V., A.O.)
700    1_
$a Heeger, Christian-Hendrik $u University Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein, Germany (R.T., C.-H.H.) $u German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Germany (R.T., C.-H.H.) $1 https://orcid.org/0000000290148097
700    1_
$a Manninger, Martin $u Medical University of Graz, Austria (D. Scherr, M.M.) $1 https://orcid.org/0000000205454373
700    1_
$a Bohnen, Jan-Eric $u Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen, Germany (R.W., J.-E.B.)
700    1_
$a Sultan, Arian $u Heart Center University Hospital of Cologne, Department for Electrophysiology, Germany (D. Steven, A.S.)
700    1_
$a Peichl, Petr $u IKEM-Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K., P.P.) $1 https://orcid.org/0000000256250071 $7 xx0092197
700    1_
$a Koopman, Pieter $u Department of Cardiology, Jessa Hospitals, Hasselt, Belgium (J.V., P.K.) $1 https://orcid.org/000000026373180X
700    1_
$a Derval, Nicolas $u IHU LIRYC, CHU Bordeaux, University of Bordeaux, France (P.J., N.D.) $1 https://orcid.org/0000000261891308
700    1_
$a Kueffer, Thomas $u Inselspital-Bern University Hospital, University of Bern, Switzerland (T.R., L.R., T.K.) $1 https://orcid.org/0000000335534945
700    1_
$a Rahe, Gilbert $u Department of Medicine, Witten/Herdecke University, Germany (K. Neven, A.F., G.R.) $u Department of Pulmonology, Gastroenterology and Internal Medicine, Alfried Krupp Hospital, Essen, Germany (G.R.)
700    1_
$a Reddy, Vivek Y $u Icahn School of Medicine at Mount Sinai, New York, NY (M.K.T., V.Y.R.) $u Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czechia (P.N., M.F., J.P., V.Y.R.) $1 https://orcid.org/0000000256384993
773    0_
$w MED00001091 $t Circulation $x 1524-4539 $g Roč. 148, č. 1 (2023), s. 35-46
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37199171 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105440 $b ABA008
999    __
$a ok $b bmc $g 2000452 $s 1203294
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 148 $c 1 $d 35-46 $e 20230518 $i 1524-4539 $m Circulation (New York, N.Y.) $n Circulation (New York) $x MED00001091
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...